Current State‐of‐the‐Art and Future Advancements of Model‐Based Meta‐Analysis
CPT: Pharmacometrics & Systems Pharmacology · 2026-07 · 15 (7)
DOI: 10.1002/psp4.70297 ↗Kurz gefasst
Editorial in der Zeitschrift CPT: Pharmacometrics & Systems Pharmacology, online erschienen am 12.07.2026. Verfasst von Phyllis Chan und 4 weiteren Autor:innen. Beteiligte Einrichtung: Genentech, Inc., South San Francisco, California, USA. Die Arbeit nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Autor:innen und Institutionen
- Genentech, Inc., South San Francisco, California, USA.
- GSK, Brentford, UK.
- Certara USA, Inc., Radnor, Pennsylvania, USA.
- Janssen-Cilag BV, Breda, the Netherlands.
- Johnson & Johnson, Spring House, Pennsylvania, USA.
ORCID-Profile: Phyllis Chan, Matthew L Zierhut, Jonathan French
Zitieren
APA
Chan, P., Simeoni, M., Zierhut, M. L., Maringwa, J., & French, J. (2026). Current State‐of‐the‐Art and Future Advancements of Model‐Based Meta‐Analysis. CPT: Pharmacometrics & Systems Pharmacology, 15(7). https://doi.org/10.1002/psp4.70297
Vancouver
Chan P, Simeoni M, Zierhut ML, Maringwa J, French J. Current State‐of‐the‐Art and Future Advancements of Model‐Based Meta‐Analysis. CPT: Pharmacometrics & Systems Pharmacology. 2026;15(7). doi:10.1002/psp4.70297
BibTeX
@article{Chan2026,
author = {Chan, Phyllis and Simeoni, Monica and Zierhut, Matthew L and Maringwa, John and French, Jonathan},
title = {Current State‐of‐the‐Art and Future Advancements of Model‐Based Meta‐Analysis},
journal = {CPT: Pharmacometrics & Systems Pharmacology},
year = {2026},
volume = {15},
number = {7},
doi = {10.1002/psp4.70297}
}
EUVIMED